South Korea
· Delayed Price · Currency is KRW CXI Healthcare Technology Group Statistics
Total Valuation
CXI Healthcare Technology Group has a market cap or net worth of KRW 27.38 billion. The enterprise value is -121.49 billion.
| Market Cap | 27.38B |
| Enterprise Value | -121.49B |
Important Dates
The next estimated earnings date is Thursday, October 17, 2024.
| Earnings Date | Oct 17, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CXI Healthcare Technology Group has 288.23 million shares outstanding. The number of shares has increased by 38.69% in one year.
| Shares Outstanding | 288.23M |
| Shares Change (YoY) | +38.69% |
| Shares Change (QoQ) | +24.32% |
| Owned by Insiders (%) | 30.50% |
| Owned by Institutions (%) | n/a |
| Float | 174.20M |
Valuation Ratios
The trailing PE ratio is 0.98.
| PE Ratio | 0.98 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.78 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 62.18, with a Debt / Equity ratio of 0.00.
| Current Ratio | 62.18 |
| Quick Ratio | 61.71 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | n/a |
| Interest Coverage | 2,740.07 |
Financial Efficiency
Return on equity (ROE) is 4.85% and return on invested capital (ROIC) is 2.40%.
| Return on Equity (ROE) | 4.85% |
| Return on Assets (ROA) | 2.38% |
| Return on Capital (ROIC) | 2.40% |
| Revenue Per Employee | 6.72B |
| Profits Per Employee | 2.10B |
| Employee Count | 10 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 209.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -12.61% |
| 50-Day Moving Average | 88.32 |
| 200-Day Moving Average | 107.45 |
| Relative Strength Index (RSI) | 60.99 |
| Average Volume (20 Days) | 8,666,732 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CXI Healthcare Technology Group had revenue of KRW 67.19 billion and earned 21.01 billion in profits. Earnings per share was 97.34.
| Revenue | 67.19B |
| Gross Profit | 26.09B |
| Operating Income | 16.60B |
| Pretax Income | 21.01B |
| Net Income | 21.01B |
| EBITDA | 41.16B |
| EBIT | 16.60B |
| Earnings Per Share (EPS) | 97.34 |
Balance Sheet
The company has 148.99 billion in cash and 124.90 million in debt, giving a net cash position of 148.86 billion or 516.47 per share.
| Cash & Cash Equivalents | 148.99B |
| Total Debt | 124.90M |
| Net Cash | 148.86B |
| Net Cash Per Share | 516.47 |
| Equity (Book Value) | 448.05B |
| Book Value Per Share | 1,516.60 |
| Working Capital | 160.44B |
Cash Flow
| Operating Cash Flow | 42.61B |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 38.83%, with operating and profit margins of 24.70% and 31.27%.
| Gross Margin | 38.83% |
| Operating Margin | 24.70% |
| Pretax Margin | 31.26% |
| Profit Margin | 31.27% |
| EBITDA Margin | 61.25% |
| EBIT Margin | 24.70% |
| FCF Margin | n/a |
Dividends & Yields
CXI Healthcare Technology Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.69% |
| Shareholder Yield | -38.69% |
| Earnings Yield | 102.46% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 29, 2016. It was a forward split with a ratio of 1.05.
| Last Split Date | Jun 29, 2016 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
CXI Healthcare Technology Group has an Altman Z-Score of 7.62.
| Altman Z-Score | 7.62 |
| Piotroski F-Score | n/a |